The Bone Marrow Immune Microenvironment in CML: Treatment Responses, Treatment-Free Remission, and Therapeutic Vulnerabilities

PURPOSE OF REVIEW: Tyrosine kinase inhibitors (TKIs) are very successful for the treatment of chronic myeloid leukaemia (CML) but are not curative in most patients due to persistence of TKI-resistant leukaemia stem cells (LSCs). The bone marrow immune microenvironment (BME) provides protection to th...

Descripción completa

Detalles Bibliográficos
Autores principales: Patterson, Shaun David, Copland, Mhairi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Chronic Myeloid Leukemias (V Oehler, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995533/
https://www.ncbi.nlm.nih.gov/pubmed/36780103
http://dx.doi.org/10.1007/s11899-023-00688-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995533/
https://www.ncbi.nlm.nih.gov/pubmed/36780103
http://dx.doi.org/10.1007/s11899-023-00688-6

Ejemplares similares